Birmingham, West Midlands -- (SBWIRE) -- 12/19/2013 -- Value Penny Stocks issues special report on Novavax, Inc. (NASDAQ:NVAX), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Integrated Device Technology Inc (NASDAQ:IDTI).
Novavax, Inc. (NASDAQ:NVAX) ended its recent business day with the gain of 0.89% and closed at the price of $4.51 after opening at $4.48. The stock traded during its last trading session with the total volume of 5,931,382 shares, as compared to its average volume of 4.68 million shares. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
For How Long NVAX will Fight for Profitability? Read This Trend Analysis report
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) remained among the day decliners and traded with volume of 5,655,554 shares in the last session, as compared to average volume of 758,920.00 million shares. In comparison with 52 week range of $6.92 - $13.15, it faced lowest price of $8.15 during the last trading session whereas its day highest price was $8.25. The company’s total market capitalization is $495.69 million, along with 60.16 million shares outstanding. Spectrum Pharmaceuticals, Inc., a biotechnology company, engages in acquiring, developing, and commercializing prescription drug products primarily in the areas of hematology and oncology.
Has SPPI Found The Bottom And Ready To Gain Momentum? Find Out Here
Halozyme Therapeutics, Inc. (NASDAQ:HALO) showed 5,499,596 shares in volume during the last trading session, while the average trading volume remained 1.32 million shares. The stock kicked off its trading session at $12.65 and closed at $14.75 after mounting 16.60%. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
Will HALO Continue To Move Higher? Find Out Here
Integrated Device Technology Inc (NASDAQ:IDTI) stock traded during its last trading session with the total traded volume of 5,414,400 shares versus its average volume of 1.34 million shares. The company opened its trade at the price of $10.16 and its closing price was $10.03 after losing -3.37% for the day. Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of mixed signal semiconductor solutions for the communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer.
Will IDTI Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)